Logo image of KALV

KALVISTA PHARMACEUTICALS INC (KALV) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:KALV - US4834971032 - Common Stock

15.31 USD
+0.71 (+4.86%)
Last: 1/20/2026, 8:00:02 PM
15.3 USD
-0.01 (-0.07%)
Pre-Market: 1/21/2026, 8:41:36 AM
Buy % Consensus

87

ChartMill assigns a Buy % Consensus number of 87% to KALV. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 33.89. This target is 121.34% above the current price.
  • KALV was analyzed by 15 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about KALV.
  • In the previous month the buy percentage consensus was at a similar level.
  • KALV was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
KALV Historical Analyst RatingsKALV Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -100 -91 -82 -73 -64 -55 -46 -37 -28 -19 -10 -1 5 10 15

Price Target & Forecast

Price Low Median Mean High 15.3122.2235.7033.8940.95 - 45.13% 133.18% 121.34% 167.47%
KALV Current Analyst RatingKALV Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6
Up and Down Grades
Date Firm Action Rating
2026-01-09 Needham Maintains Buy -> Buy
2026-01-09 HC Wainwright & Co. Maintains Buy -> Buy
2026-01-06 Needham Maintains Buy -> Buy
2025-12-04 Needham Reiterate Buy -> Buy
2025-11-11 Citizens Maintains Market Outperform -> Market Outperform
2025-09-12 JMP Securities Maintains Market Outperform -> Market Outperform
2025-09-12 Needham Reiterate Buy -> Buy
2025-07-11 HC Wainwright & Co. Reiterate Buy -> Buy
2025-07-08 JMP Securities Maintains Market Outperform -> Market Outperform
2025-07-08 HC Wainwright & Co. Maintains Buy -> Buy
2025-07-07 Leerink Partners Maintains Outperform -> Outperform
2025-04-08 Needham Reiterate Buy -> Buy
2025-03-26 Citizens Capital Markets Reiterate Market Outperform -> Market Outperform
2025-03-26 Jones Trading Maintains Buy -> Buy
2025-03-26 Needham Reiterate Buy -> Buy
2025-03-14 HC Wainwright & Co. Reiterate Buy -> Buy
2025-03-13 Needham Reiterate Buy -> Buy
2025-03-03 Citizens Capital Markets Reiterate Market Outperform -> Market Outperform
2025-01-31 JMP Securities Initiate Market Outperform
2025-01-07 TD Cowen Initiate Buy
2024-12-18 B of A Securities Initiate Buy
2024-12-09 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-12-06 HC Wainwright & Co. Reiterate Buy -> Buy
2024-12-05 Needham Reiterate Buy -> Buy
2024-10-07 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-27 Jones Trading Initiate Buy
2024-09-09 Cantor Fitzgerald Reiterate Overweight
2024-09-06 Needham Reiterate Buy -> Buy
2024-09-06 HC Wainwright & Co. Reiterate Buy -> Buy
2024-07-15 HC Wainwright & Co. Reiterate Buy -> Buy

KALVISTA PHARMACEUTICALS INC / KALV FAQ

What do analysts expect the price target to be for KALVISTA PHARMACEUTICALS INC (KALV)?

15 analysts have analysed KALV and the average price target is 33.89 USD. This implies a price increase of 121.34% is expected in the next year compared to the current price of 15.31.


What is the consensus rating for KALV stock?

The consensus rating for KALVISTA PHARMACEUTICALS INC (KALV) is 86.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.